Table 5.
The comparison between estimated-value and actual-value
| Actual value | Estimated value | T/W/χ2 | p-value | |
|---|---|---|---|---|
| ICG-R15 combined with SNLR (before PSM) | ||||
| ICG-R15 (%) | 10.04 ± 10.04 | 10.05 ± 7.45 | − 0.20 | 0.984 |
| ICG-R15 (%) | 6.05 (3.43–12.95) | 8.64 (5.12–13.69) | 24,943.000 | 0.092 |
| ICG-R15 ≥ 10% (n) | 97 | 127 | 6.411 | 0.011 |
| ICG-R15 combined with SNLR (after PSM) | ||||
| ICG-R15 (%) | 12.11 ± 2.35 | 12.10 ± 3.23 | − 0.005 | 0.996 |
| ICG-R15 (%) | 9.95(5.13–15.08) | 11.35 (9.90–13.15) | 3870.000 | 0.189 |
| ICG-R15 ≥ 10% (n) | 58 | 87 | 15.467 | < 0.001 |
| ICG-R15 purely based on serology | ||||
| ICG-R15 (%) | 10.04 ± 10.04 | 10.11 ± 7.29 | − 0.142 | 0.877 |
| ICG-R15 (%) | 6.05(3.43–12.95) | 9.26 (5.06–13.87) | 25,237.000 | 0.060 |
| ICG-R15 ≥ 10% (n) | 97 | 132 | 8.651 | 0.003 |